Pharmaceutical

Korro Bio enters merger deal with Frequency Therapeutics

Korro Bio has signed a definitive merger agreement with Frequency Therapeutics to create a genetic medicines firm.

Jul 17, 2023 - 20:00
Korro Bio enters merger deal with Frequency Therapeutics
Korro Bio has signed a definitive merger agreement with Frequency Therapeutics to create a genetic medicines firm.
Read the original article

Tags:

Previous Article

Vivoryon issues updates on its Alzheimer’s therapy programme

Next Article

Lilly to acquire biopharma firm Versanis for $1.9bn

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Novartis touts breast cancer win with “landmark” Kisqali results

Novartis touts breast cancer win with “landmark” Kisqal...

Jun 3, 2023

STAT+: Skin patch for toddlers with peanut allergy shows promising results in late-stage trial

STAT+: Skin patch for toddlers with peanut allergy show...

May 11, 2023

SGN-1 by Guangzhou Sinogen Pharmaceutical for Head And ...

Dec 4, 2023